Abstract:Matrix metalloproteinases (MMPs) play important roles in many diseases including cancer. With moderate metal-binding affinity, 8-hydroxyquinoline has gained much interest in current drug design and development. Specially, it has been reported that 8-hydroxyquinoline derivatives serve as MMP-2 inhibitors with micromolar IC50 values. In the current study, a series of 8-hydroxyquinoline derivatives were designed and synthesized as new MMP-2 and MMP-9 inhibitors. The most active compounds 5e and 5h not only displayed good inhibitory activities against MMP-2/9 with IC50 at submicromolar level, but also possessed potent anti-proliferative, anti-invasive and anti-angiogenesis activity in A549 cell line. Western blot also revealed that 5e and 5h down-regulate the expression of MMP-2 and MMP-9 in A549 cell line. Moreover, flow cytometry analysis indicated that compound 5e could promote apoptosis of A549 cells in vitro. Molecular docking analysis also revealed favorable binding modes of 5e in the active sites of MMP-2 and MMP-9.

Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

Design, Synthesis, and Primary Activity Evaluation of Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors.

Design, Synthesis and Preliminary Evaluation of Novel Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Sulfonyl Phosphonic 1,4-Dithia-7-azaspiro[4,4]nonane Derivatives As Matrix Metalloproteinase Inhibitors: Synthesis, a Docking Study, and Biological Evaluation.

[Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].

Synthesis of New Sulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

Design, Synthesis, and Biological Evaluation of 4-Phenoxybenzenesulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Design, Synthesis and Biological Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives As Aminopeptidase N/CD13 Inhibitors.

Design, Synthesis and Preliminary Activity Evaluation of Novel Peptidomimetics As Aminopeptidase N/CD13 Inhibitors

Novel 3-Galloylamido-n′-substituted-2,6-piperidinedione-n-acetamide Peptidomimetics As Metalloproteinase Inhibitors

The Synthesis and Preliminary Activity Assay in Vitro of Peptide-Like Derivatives As APN Inhibitors

Design, Synthesis, Evaluation and 3D-QSAR Analysis of Benzosulfonamide Benzenesulfonates As Potent and Selective Inhibitors of MMP-2

Design, Synthesis and Primary Activity Assay of Bi- or Tri-Peptide Analogues with the Scaffold L-Arginine As Amino-Peptidase N/CD13 Inhibitors

Design, Synthesis, and QSAR Studies of Novel Lysine Derives As Amino-Peptidase N/CD13 Inhibitors.

Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.

Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.

Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives As Proteasome Inhibitors

Design, Synthesis, and Biological Evaluation of Novel Phenol Ether Derivatives As Non-Covalent Proteasome Inhibitors.

Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.

Design, Synthesis and Preliminary Evaluation of New Cinnamoyl Pyrrolidine Derivatives As Potent Gelatinase Inhibitors